RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer

Abstract

Background RelA/p65 a crucial member of NF-κB signaling pathway plays diverse role in mediating oncogenesis. Limited knowledge prevails on the mechanistic insights of RelA gene regulation. RNA helicase p68 apart from being a vital player of RNA metabolism acts as a transcriptional coactivator of several oncogenic transcription factors including β-catenin and is highly implicated in cancer progression. In this study, we aim to discern the molecular mechanism of how an RNA helicase, p68 deploys a major oncogenic signaling pathway, Wnt/ β-catenin to regulate the expression of RelA, an indispensable component of NF-κB signaling pathway towards driving colon carcinogenesis. Methods Immunoblotting and quantitative RT-PCR was performed for determining the protein and mRNA expressions of the concerned genes respectively. Luciferase assay was employed for studying the promoter activity of RelA. Chromatin immunoprecipitation was used to evaluate the occupancy of transcription factors on the RelA promoter. Immunohistochemical analysis was conducted using FFPE sections derived from normal human colon and colon cancer patient samples. Finally, a syngeneic colorectal allograft mouse model was used to assess physiological significance of the in vitro findings. Results p68, β-catenin and RelA proteins were found to bear strong positive correlation in normal and colon carcinoma patient samples. Both p68 and β-catenin increased RelA mRNA and protein expression. p68, β-catenin and Wnt3a elevated RelA promoter activity. Conversely, p68 and β-catenin knockdown diminished RelA promoter activity and led to reduced RelA mRNA and protein expression. p68 was perceived to occupy RelA promoter with β-catenin at the TCF4/LEF (TBE) sites thereby potentiating RelA transcription. p68 and β-catenin alliance positively modulated the expression of signature NF-κB target genes. Enhanced NF-κB target gene expression by p68 was corroborated by findings in clinical samples. Tumors generated in mice colorectal allograft model, stably expressing p68 further reinforced our in vitro findings. Conclusions We report for the first time a novel mechanism of alliance between p68 and β-catenin in regulating the expression of RelA and stimulating the NF-κB signaling axis towards driving colon carcinogenesis. This study unravels novel modes of p68-mediated colon carcinogenesis, marking it a potential target for therapy. Electronic supplementary material The online version of this article (10.1186/s13046-019-1304-y) contains supplementary material, which is available to authorized users.

DDX54 Plays a Cancerous Role Through Activating P65 and AKT Signaling Pathway in Colorectal Cancer

“…In another research, the authors found p68, also named as DDX5, and β-catenin increased RelA mRNA and protein expression. DDX5 was perceived to associate with RelA promoter while β-catenin at the TCF4/LEF (TBE) sites thereby potentiating RelA transcription ( 31 ). DDX27 was also observed to be highly expressed in CRC tissues and increased the proliferation and motility through promote p65 to bind to the promoter region of its target genes ( 10 ).…”

Circular RNA GLIS2 promotes colorectal cancer cell motility via activation of the NF-κB pathway

“…TRAF6 activates NF-κB via the nuclear shuttling effect of p65 in CRC 30 . RNA helicase p68 enhanced NF-κB target genes expression by directly promoting p65 transcription 31 . Our research introduced a new mechanism that helps understand the NF-κB pathway in CRC.…”

Identification and validation of E3 ubiquitin ligase XIAP as a novel substrate of deubiquitinase USP7 (HAUSP) - Implication towards oncogenesis

“…Total RNA was extracted using Trizol reagent (Invitrogen) and processed for real-time PCR as previously described 19 . Briefly, cDNA was prepared, and Real-time PCR was performed using SYBR Green Master Mix (Bio-Rad) in Via7 Real-Time PCR Instrument (Applied Biosystems), described before.…”